This is a 47-chapter non-fiction story about Mercury poisoning from my eight dental amalgams and one root canal. I had fillings since age eight at least. The World Health Organization states that 87% of Mercury poisoning in humans comes from their mouth. Amalgam fillings are 50-52% Mercury.
Childhood vaccinations with 'Thimersol;' a Mercury based derivative only add to the problem. They are becoming much more profuse now. Even flu shots use Mercury as a preservative. When I asked to have my root canal tooth pulled by an experienced dental surgeon, he said that the Mercury had leaked up my right sinus a great distance. This is the side that the root canal was on. I had an amalgam tattoo above the root canal too.
Nutrition and hand washing are the way to beat illness. My deep faith has helped me through much brutality, both physical and emotional. It's all documented. I'll close with what I believe and say, "God sees it all." This belief got me through everything.
I published this book because my deepest desire is to help others; they need not go through what I went through.
Dental Amalgam Mercury Syndrome International (DAMS)
Contact websites; www.dams.cc OR www.noamalgams.org
Telephone number: 1-800-311-6265
Andrew Hall-Cutler, PE, PhD
Telephone number: (425)-557-8299
Website: www.noamalgams.com Email: [email protected]
For incredible health naturally, contact www.achew.com
I bought my 'Pure Charge' machine from him.
Angie Spizzirri - health consultant, works using the most helpful ancient Egyptian dowsing also. She lives in Toronto, Ontario and can work long distance. Her telephone number is (416) 464-7463; Cell (416) 509-2148. She is incredible and I highly recommend her.
'Metagenics' products I sell to the clients of my business. I have become a partner to the 'Metagenics' business because I am a registered nurse who has a deep desire to help others. They have a branch that makes the products in Mississauga, Ontario. They produce the best natural vitamins, minerals, amino acids, essential fatty acids and high cholesterol healing natural medicine.Website: www.metagenics.com
I am a member of the 'Nikken' corporation and sell their products or help to make others a part of the business so that they get their products wholesale. They have the best in magnetic products, even mattresses. Their magnets are the highest quality. Magnets in a drug store or other stores don't get near the quality. Magnets heal the body from pain and are part of the earth's core; we need to bring them closer for benefits.
Their website is: www.nikken.com
I also am a member of 'Mannatech, ' you can be too. Their 'Ambrotose' is patented and is revolutionary in helping people. It is food also.
Website: www.mannatech.com
Cell Phone E.M.F. Harmonizer by 'BioPro. They last for the life of your cell phone. They are simple, round and go on the phone. They have been medically proven to prevent brain tumors'. I sell these for $40.00 Cdn.
Website: www.bioprotechnology.com

Malpractice settlements are large for undetected hydroxychloroquine and chloroquine toxicity which, if untreated, can lead to permanent loss of central vision. Knowledge of the ocular toxicity of these drugs has increased during the past fifty years as their use has expanded. Hydroxychloroquine and Chloroquine Retinopathy is the first single-source book on the subject and is essential for the practicing ophthalmologists, rheumatologists, dermatologists, and internists who prescribe these drugs. It covers clinical topics such as signs and symptoms of toxicity, toxicity screening, ancillary testing, to whom and why the drugs are prescribed and dosing considerations. Additionally, the book addresses practice management considerations, including coding, reimbursement and equipment costs, and the medico-legal responsibilities of the rheumatologist and of the ophthalmologist. Guidelines for the management of hydroxychloroquine and chloroquine vary around the world and differences between the guidelines of the United Kingdom, the United States, and other countries are identified. The book concludes with a collection of case examples illustrating common clinical scenarios and their management. This book is a "must-have" resource for physicians who use these drugs.

Pathophysiology and Analysis.- Lipid Peroxides and Related Radicals in Clinical Medicine.- Reactive Oxygen Species in Normal Physiology, Cell Injury and Phagocytosis.- Free Radical Mechanisms for Chromosomal Instability in Bloom's Syndrome.- The Analysis of Free Radicals, Lipid Peroxides, Antioxidant Enzymes and Compounds Related to Oxidative Stress as Applied to the Clinical Chemistry Laboratory.- Organ Specific Disorders.- Free Radicals and the Pathogenesis of Neuronal Death: Cooperative Role of Excitatory Amino Acids>.- Free Radicals and Ocular Disease.- Active Oxygen Mechanisms of UV Inflammation.- Oxygen-Free Radicals at Myocardial Level: Effects of Ischaemia and Reperfusion.- Mechanisms of Atherosclerosis: Role of LDL Oxidation.- Tissue Iron Overload and Mechanisms of Iron-Catalyzed Oxidative Injury.- Free Radicals in the Pathophysiology of Pulmonary Injury and Disease.- Lipid Peroxides in Hepatic, Gastrointestinal, and Pancreatic Diseases.- Reactive Oxygen Molecules in the Kidney.- Reactive Oxygen Species (ROS) and Reproduction.- Systemic Involvement.- Autoimmune and Inflammatory Diseases.- Antioxidants and Cancer: Molecular Mechanisms.- New Directions for Free Radical Cancer Research and Medical Applications.- Shock and Multiple Organ Failure.- Role of Nutrients in the Cause and Prevention of Oxygen Radical Pathology.- Involvement of Free Radical Mechanism in the Toxic Effects of Alcohol: Implications for Fetal Alcohol Syndrome.- Therapeutic Intervention.- 21-Aminosteroids ("Lazaroids").- The Potential of Gliclazide, a Sulphonylurea to Influence the Oxidative Processes within the Pathogenesis of Diabetic Vascular Disease.- Interactions between Vitamin E, Free Radicals, and Immunity During the Aging Process.- Vitamins and Carotenoids - A Promising Approach to Reducing the Risk of Coronary Heart Disease, Cancer and Eye Diseases.- Free Radical Scavenging and Antioxidant Activity of Plant Flavonoids.- Plasma Clearance and Immunologic Properties of Long-Acting Superoxide Dismutase Prepared Using 35,000 to 120,000 Dalton Poly-Ethylene Glycol.- Clinical Trials with Dismutec(TM) (Pegorgotein; Polyethylene Glycol-Conjugated Superoxide Dismutase; PEG-SOD) in the Treatment of Severe Closed Head Injury.- Poster Presentations.- A New Method for Detecting Lipid Peroxidation by Using Dye Sensitized Chemiluminescence.- Chemiluminescence and the Challenge to Attomole Detection.- Evidence Against Malondialdehyde Bound to Cellular Consituents in Phospholipid Peroxidation.- Evaluation of In Vivo Free Radical Activity During Endotoxic Schock Using Scavengers, Electron Microscopy, Spin Traps, and Electron Paramagnetic Spectroscopy.- Involvement of Hydroxyl Radicals in Endotoxin-Evoked Shock.- The Role of Nitric Oxide in Endotoxin-Elicited Hypodynamic Circulatory Failure.- In Vivo Evaluation of the Role of Neutrophil-Derived Free Radicals in the Development of Endotoxic Shock.- Photosensitized Formation of 8-Hydroxy-2'-Deoxyguanosine by A Cationic meso-Substituted Porphyrin.- Aging Associated Declines in the Antioxidant Enzymes of Human Testis.- Lipid Peroxidation in Normal Pregnancy and Preeclampsia.- Alkylation of Purine Bases By Carbon-Centered Radicals.- Cytochrome Biochemistry in Sheep Retina Following Exposure to Oxygen.- Cytochrome Oxidase Activity in the Fetal Sheep Retina.- Age-Related Phospholipid Hydroperoxide Levels in Gerbil Brain Measured by HPLC-Chemiluminescence Assay and Their Relation to Hydroxyl Radical Stress - Clinical Implications.- Lipid Peroxidation and Diabetic Complications: Effect of Antioxidant Vitamins C and E.- Vascular Complications of Patients in Kuwait with Type 2 Diabetes Mellitus (NIDDM) and Elevated Serum Lipid Peroxides.- Vascular and Cellular Protein Changes Precede Hippocampal Pyramidal Cell Loss Following Global Ischemia in the Rat.- Dietary Antioxidants and Breast Cancer Risk: Effect Modification by Family History.- Effect of MAK-4 and MAK-5 on Endothelial Cell- and Soyabean Lipoxygenase-Induced LDL Ox

The whole field of drug research has become a minefield of sensitive issues with the opponents entrenched at opposite extremes taking pot shots at each other. The attacks made on drug research and the pharmaceutical industry in particular have become so venomous that an attempt needed to be made to provide a balanced ethical appraisal of the situation. Neither pro- nor antagonists are fully right, but some common grounds need to be found. The author believes that this commons grounds resides in the religious and philosophical foundations on which western industrial society has been built.

Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry with an emphasis on emerging topics in the biological sciences that are expected to provide the basis for entirely new future therapies.

This new volume of Advances in Pharmacology presents pharmacology of the blood brain barrier, focusing on targeting CNS disorders. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.

Topics in this clinically focused publication devoted to Anticoagulants are: Antithrombin clinical applications and anti-inflammatory effects; Pharmacology and laboratory testing of oral direct thrombin inhibitor Dabigatran; Pharmacology and laboratory testing of the oral Xa inhibitors; Clincial use of the new oral anticoagulants; Pharmacology and safety of new oral anticoagulants-the challenge of bleeding; Emergency reversal of Warfarin anticoagulation - prothrombin complex concentrate compared with plasma; Prothrombin complex concentrate as reversal agent for new oral anticoagulants - lessons from prelinical models; Bleeding with new oral anticoagulants - clinical presentation and management; Treatment of ICH with new oral anticoagulants - a neurologist's view; Management of anticoagulation agents in trauma patients; and Anticoagulation and pediatric patients.

This issue of Heart Failure Clinics examines the pharmacologic approaches to heart failure: optimizing established therapy with a look toward future agents. Topics include the pathophysiologic foundation for the pharmacologic treatment of heart failure, treatment of heart failure with reducted ejection fraction and preserved ejection fraction, treatment of acute heart failure, investigational treatments, and the role of congestive heart failure medications following left ventricular assist device.

This book presents a comprehensive and up to date account of the chemotherapy of parasitic diseases, both human and veterinary. The book starts with an overview of parasitic diseases. The body of the book is divided into two parts: antihelminthic drugs, and antiprotozoal drugs. Both parts start with chapters highlighting the 'biochemical targets' available for chemotherapeutic interference. Individual chapters deal with one chemical class of compounds and describe their origin, structure-activity relationship, mode of action, and methods of synthesis and their status both in clinical and veterinary practice. The book will be useful to a wide spectrum of readers: students embarking on a research career in parasitic chemotherapy, clinicians (and veterinarians) and clinical pharmacologists desiring detailed information about the drugs currently in use, and pharmaceutical technologists wanting to update their knowledge of the methods of manufacture.

The cyclic purine nucleotides 3',5'-cAMP and 3',5'-cGMP are well-established second messengers. cGMP has recently been covered in a volume of the Handbook of Experimental Pharmacology (volume 191). In addition to 3',5'-cAMP and 3',5'-cGMP, so-called non-canonical cyclic nucleotides exist. These comprise the cyclic pyrimidine nucleotides 3',5'-cCMP and 3',5'-cUMP, the purine nucleotide 3',5'-cIMP, the 2',3'-nucleoside monophosphates and cyclic dinucleotides. In this volume of the Handbook of Pharmacology, word-leading experts in the field summarize our current knowledge on these non-canonical cyclic nucleotides, discuss open questions, future research directions and the pharmacotherapeutic implications. Special emphasis will be given to the emerging roles of 3',5'-cCMP and 3',5'-cUMP as second messengers with regard to generators, effectors, biological functions, inactivation and bacterial toxins. The role of 3',5'-cIMP as potential second messenger will also be critically discussed. Furthermore, we will consider transport of cyclic nucleotides and their potential role as first messengers. The role of the cyclic dinucleotide cGAMP in the immune system will covered, too. Lastly, the book will present important methodological aspects ranging from mass-spectrometric methods for cyclic nucleotide detection to the synthesis of nucleotide analogs as experimental tools and holistic methods for analysis of cyclic nucleotide effects.

The Heart and Toxins brings together global experts to provide the latest information and clinical trials that make the connection between genetic susceptibility, gene expression, and environmental factors in cardiovascular diseases. This unique reference, edited by renowned cardiologist Meenakshi Sundaram Ramachandran, solves the problem of managing multiple clinical cases of cardiovascular toxicity. It allows connections to be made between research, diagnosis, and treatment to avoid higher morbidity and mortality rates as a result of cardiovascular toxicity.

Chemistry. Tetrahydrobiopterin Dependent Hydroxylases. Tetrahydrobiopterin Regenerating Enzymes. Tetrahydrobiopterin Biosynthesis. Tetrahydrobiopterin Regulation. Tetrahydrobiopterin Deficiency. Nitric Oxide Synthase. Other Functions of Tetrahydrobiopterins. Molybdopterin Cofactors. Synthesis and Biological Evaluation of AntiFolates. Dihydrofolate Reductase. Thymidylate Synthase. Folylpolyglutamate Synthetase and Hydrolase. OneCarbon Metabolism. Folate Nutrition and Transport. 165 articles. Index.

The discovery of the anti-tumour activity of cisplatin in 1965, and its subsequent introduction into clinical trials in 1971, was the catalyst for a major research effort into the potential of metal compounds in cancer therapy. This book provides a discussion of metal compounds in cancer therapy. This book should be of interest to research workers in the pharmaceutical industry, particularly tumour pharmacologists, tumour biologists, medicinal chemists and oncologists.

"Applied Dermatotoxicology: Clinical Aspects" provides concise, systematic, and state-of-the-art information on the toxicological effects of substances on skin, and recent advances in dermal toxicity testing.

This book specifically addresses the clinical presentations borne out of exposure to a variety of chemicals. It begins with an overview of skin biology to provide toxicologists with a basic understanding of its anatomy and physiology. Next it presents a variety of dermatotoxicological effects, as well at the toxic agents that cause them, with color photographs to illustrate these effects.

"Applied Dermatotoxicology: Clinical Aspects" is an essential reference for toxicologists in industry, and for those medical professionals who encounter cases of dermal exposure to toxic agents.
A concise, yet inclusive review of effects of chemical exposureIncludes background on basic skin biologyProvides vital clinical reference for toxicologists in non-clinical settings

This authoritative volume explores advances in the techniques used to measure percutaneous penetration of drugs and chemicals to assess bioavailability and bioequivalence and discusses how they have been used in clinical and scientific investigations. Seven comprehensive sections examine topics including in vitro drug release, topical drugs products, clinical studies, and guidelines and workshop reports, among others. The book also describes how targeted transdermal drug delivery and more sophisticated mathematical modelling can aid in understanding the bioavailability of transdermal drugs. The first edition of this book was an important reference guide for researchers working to define the effectiveness and safety of drugs and chemicals that penetrated the skin. This second edition contains cutting-edge advances in the field and is a key resource to those seeking to define the bioavailability and bioequivalence of percutaneously active compounds to improve scientific and clinical investigation and regulation.

This second edition provides up-to-date chapters and new chapters focusing on the most recent advances in the field of drug safety evaluation. Divided into seven parts, chapters detail specific aspects related to the experimental design of preclinical studies conducted to support the safety of pediatric and combination drugs, necropsy and histopathology evaluation, mass spectrometry imaging, genetic toxicology protocols including the Pig-a mutation assay, safety pharmacology methods such as automatization of patch-clamp procedures, target safety assessment for investigative toxicology, screening assays for developmental toxicology, and methods to characterize novel translational safety biomarkers like microRNAs. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting to avoid known pitfalls. Authoritative and practical, Drug Safety Evaluation: Methods and Protocols, Second Edition aims to ensure successful results in the further study of this vital field.

For some years, international guidelines on the management of asthma have stressed the importance of early intervention with anti-inflammatory drugs to prevent acute asthma exacerbations and to avert chronic inflammatory damage to the airway. Introduced by a broad survey of the targets for anti-inflammatory drugs, this book proceeds to bring together the most recent research into the mechanisms and clinical benefits of presently available anti-inflammatory treatments including corticosteroids, cromones, and theophylline. For the first time, these drugs are discussed alongside the newly introduced leukotriene modifier drugs, and in the context of frontline research into anti-inflammatory drugs of the future. Leading authorities in their fields evaluate the prospects of novel anti-IgE agents and cytokine antagonists, and examine recent developments in immunosuppressant compounds, protease inhibitors, and selective phosphodiesterase inhibitors. This book is an up-to-date and authoritative survey which will be invaluable to university and pharmaceutical company researchers working on anti-asthma and anti-allergy drugs and to respiratory physicians keeping abreast of developments in their specialty.

This book encompasses major progress and future directions in cytochrome P450 (P450) research. Included are contributions by pioneers in the discovery of P450, with chapters on the molecular and functional properties of P450 and cutting-edge applications knowledge from various fields. P450 research has its roots in metabolism, but the true beginning was in 1962 with the publication by Tsuneo Omura and Ryo Sato in "The Journal of Biological Chemistry "on their discovery of the cytochrome." "Following this groundbreaking study, over the last half-century, research has revealed that many forms of P450 exist in animals, plants and microorganisms. P450 research has expanded into many different fields including medicine, agriculture and biotechnology and has drawn the attention of industries for its bioengineering applications, such as drug development and creation of the blue rose . Also, research on nuclear receptors, which has grown out of research on the regulatory mechanisms of P450 genes, has become an important area in biology, medical science, pharmacology and clinical medicine for example, with recent developments in personalized medicines. This book will draw readers into the important and exciting world of P450 and will encourage young students and scientists in P450 research to continue expanding the field via new approaches."

"Biochemical Ecotoxicology: Principles and Methods" presents practical approaches to biochemical ecotoxicology experiments for environmental protection and conservation.

With its methodical, stepped approach this essential reference introduces readers to current techniques for toxicity endpoint testing, suitable for laboratories of any size and budget. Each chapter presents a state-of-the-art principle, a quick and inexpensive procedure (including appropriate reagents), case studies, and demonstrations on how to analyze your results.

Generic techniques are covered, suitable for a variety of organisms, as well as high-throughput techniques like quantitative polymerase chain reactions and enzyme-linked immunoassays. Cutting-edge approaches, including microarrays and omics techniques, are also included, making this is an essential reference for anyone who needs to assess environmental toxicity.
Practical, cost-effective approaches to assess environmental toxicity endpoints for all types of organismPresents theory, methods, case studies and information on how to analyze resultsState-of-the-art techniques, such as omics approaches to toxicology and microarrays "